Related Experiment Videos
Current pharmacologic treatment of multiple sclerosis symptoms
1University of California, San Francisco, School of Medicine (UCSF)-Mount Zion Multiple Sclerosis Center 94115, USA.
The Western Journal of Medicine
|November 1, 1996
Abstract:
About 350,000 persons in the United States have multiple sclerosis, and primary care physicians are often called on to provide symptomatic therapy for these patients. We review our current pharmacologic approach to the management of multiple sclerosis exacerbations and the symptoms of spasticity, fatigue, bladder and bowel involvement, neurobehavioral complaints, pain syndromes, dystonic spasms, and tremor and ataxia.